Johnson & Johnson vaccine: FDA to add new warning after link to serious nerve condition
The Johnson & Johnson Covid vaccine could be about to receive a new warning – that it could lead to increased risk of Guillain-Barre syndrome. The condition mainly affects the feet, hands and limbs, causing problems such as numbness, weakness and pain. It can sometimes be life-threatening and some people are left with long-term problems.
The cases have largely occurred around two weeks after vaccination, mostly in men, many aged 50 and older, the Centers for Disease Control and Prevention (CDC) has said.
The CDC added available data does not show a similar pattern with mRNA vaccines, after more than 321 million doses administered in the United States.
The agency will be discussing the issue at its upcoming vaccine advisory committee meeting.
The FDA did note while the available evidence suggests an association between the Johnson * Johnson vaccine and increased risk of Guillain-Barre, “it is insufficient to establish a casual relationship”.
DON’T MISS
